Search

Your search keyword '"Bredeson, Christopher N."' showing total 20 results
Start Over Author "Bredeson, Christopher N." Journal blood
20 results on '"Bredeson, Christopher N."'

2. HLA Haploidentical versus Matched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide based prophylaxis

Author

Gooptu, Mahasweta, primary, Romee, Rizwan, additional, St. Martin, Andrew, additional, Arora, Mukta, additional, Al Malki, Monzr M., additional, Antin, Joseph H., additional, Bredeson, Christopher N, additional, Brunstein, Claudio G, additional, Chhabra, Saurabh, additional, Fuchs, Ephraim J, additional, Ghosh, Nilanjan, additional, Grunwald, Michael Richard, additional, Kanakry, Christopher G, additional, Kekre, Natasha, additional, McGuirk, Joseph P, additional, McNiece, Ian, additional, Mehta, Rohtesh S., additional, Mielcarek, Marco, additional, Milano, Filippo, additional, Modi, Dipenkumar, additional, Reshef, Ran, additional, Solomon, Scott R, additional, Schroeder, Mark A, additional, Waller, Edmund K, additional, Inamoto, Yoshihiro, additional, Soiffer, Robert J., additional, and Eapen, Mary, additional

Published
2021
Full Text
View/download PDF

3. Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission

Author

Marks, David I., Pérez, Waleska S., He, Wensheng, Zhang, Mei-Jie, Bishop, Michael R., Bolwell, Brian J., Bredeson, Christopher N., Copelan, Edward A., Gale, Robert Peter, Gupta, Vikas, Hale, Gregory A., Isola, Luis M., Jakubowski, Ann A., Keating, Armand, Klumpp, Thomas R., Lazarus, Hillard M., Liesveld, Jane L., Maziarz, Richard T., McCarthy, Philip L., Sabloff, Mitchell, Schiller, Gary, Sierra, Jorge, Tallman, Martin S., Waller, Edmund K., Wiernik, Peter H., and Weisdorf, Daniel J.

Published
2008
Full Text
View/download PDF

5. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry

Author

Freytes, César O., Loberiza, Fausto R., Rizzo, J. Douglas, Bashey, Asad, Bredeson, Christopher N., Cairo, Mitchell S., Gale, Robert Peter, Horowitz, Mary M., Klumpp, Thomas R., Martino, Rodrigo, McCarthy, Philip L., Molina, Arturo, Pavlovsky, Santiago, Pecora, Andrew L., Serna, Derek S., Tsai, Tsuong, Zhang, Mei-Jie, Vose, Julie M., Lazarus, Hillard M., and van Besien, Koen

Published
2004
Full Text
View/download PDF

7. HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis

Author

Gooptu, Mahasweta, Romee, Rizwan, St. Martin, Andrew, Arora, Mukta, Al Malki, Monzr, Antin, Joseph H., Bredeson, Christopher N., Brunstein, Claudio G., Chhabra, Saurabh, Fuchs, Ephraim J., Ghosh, Nilanjan, Grunwald, Michael R., Kanakry, Christopher G., Kekre, Natasha, McGuirk, Jospeh P., McNiece, Ian K., Mehta, Rohtesh S., Mielcarek, Marco, Milano, Fillipo, Modi, Dipenkumar, Reshef, Ran, Solomon, Scott R., Schroeder, Mark A., Waller, Edmund K., Inamoto, Yoshiro, Soiffer, Robert J., and Eapen, Mary

Abstract

Posttransplant cyclophosphamide (PTCy) graft-versus-host disease (GVHD) prophylaxis has enabled haploidentical (Haplo) transplantation to be performed with results similar to those after matched unrelated donor (MUD) transplantation with traditional prophylaxis. The relative value of transplantation with MUD vs Haplo donors when both groups receive PTCy/calcineurin inhibitor/mycophenolate GVHD prophylaxis is not known. We compared outcomes after 2036 Haplo and 284 MUD transplantations with PTCy GVHD prophylaxis for acute leukemia or myelodysplastic syndrome in adults from 2011 through 2018. Cox regression models were built to compare outcomes between donor types. Recipients of myeloablative and reduced-intensity regimens were analyzed separately. Among recipients of reduced-intensity regimens, 2-year graft failure (3% vs 11%), acute grades 2 to 4 GVHD (hazards ratio [HR], 0.70; P = .022), acute grades 3 and 4 GVHD (HR, 0.41; P = .016), and nonrelapse mortality (HR, 0.43; P = .0008) were lower after MUD than with Haplo donor transplantation. Consequently, disease-free (HR, 0.74; P = .008; 55% vs 41%) and overall (HR, 0.65; P = .001; 67% vs 54%) survival were higher with MUD than with Haplo transplants. Among recipients of myeloablative regimens, day-100 platelet recovery (95% vs 88%) was higher and grades 3 and 4 acute (HR, 0.39; P = .07) and chronic GVHD (HR, 0.66; P = .05) were lower after MUD than with Haplo donor transplantation. There were no differences in graft failure, relapse, nonrelapse mortality, and disease-free and overall survival between donor types with myeloablative conditioning regimens. These data extend and confirm the importance of donor-recipient HLA matching for allogeneic transplantation. A MUD is the preferred donor, especially for transplantations with reduced-intensity conditioning regimens.

Published
2021
Full Text
View/download PDF

9. Comparison of Total Body Irradiation-Based with Intravenous Busulfan-Based Chemotherapy-Only Conditioning Regimens for Myeloablative Hematopoietic Cell Transplantation (HCT) in Adults with Acute Lymphoblastic Leukemia

Author

Kebriaei, Partow, primary, Anasetti, Claudio, additional, Zhang, Mei-Jie, additional, Wang, Hai-Lin, additional, Aldoss, Ibrahim, additional, de Lima, Marcos, additional, Khoury, H. Jean, additional, Sandmaier, Brenda M., additional, Horowitz, Mary M., additional, Artz, Andrew, additional, Bejanyan, Nelli, additional, Ciurea, Stefan O., additional, Lazarus, Hillard M., additional, Gale, Robert Peter, additional, Litzow, Mark, additional, Bredeson, Christopher N., additional, Seftel, Matthew D., additional, Pulsipher, Michael A, additional, Boelens, Jaap Jan, additional, Alvarnas, Joseph, additional, Champlin, Richard E., additional, Forman, Stephen J., additional, Pullarkat, Vinod, additional, Weisdorf, Daniel, additional, and Marks, David I., additional

Published
2016
Full Text
View/download PDF

10. Factors Influencing Long-Term Hematopoietic Function Following Autologous Stem Cell Transplantation

Author

Visram, Alissa, primary, Kekre, Natasha, additional, Bredeson, Christopher N., additional, Tay, Jason, additional, Huebsch, Lothar B., additional, McDiarmid, Sheryl, additional, Mallick, Ranjeeta, additional, Sabloff, Mitchell, additional, Atkins, Harold, additional, Allan, David S., additional, Tinmouth, Alan, additional, Hamelin, Linda, additional, Martin, Lisa, additional, and Maze, Dawn, additional

Published
2016
Full Text
View/download PDF

11. Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant

Author

Bryant, Adam, primary, Mallick, Ranjeeta, additional, Huebsch, Lothar B., additional, Allan, David S., additional, Atkins, Harold, additional, Anstee, Grizel, additional, Bence-Bruckler, Isabelle, additional, Hamelin, Linda, additional, Hodgins, Michael, additional, Sabloff, Mitchell, additional, Scrivens, Nicholas, additional, Maze, Dawn C., additional, Bredeson, Christopher N., additional, and Kekre, Natasha, additional

Published
2016
Full Text
View/download PDF

12. Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Author

Khera, Nandita, primary, Majhail, Navneet S., additional, Brazauskas, Ruta, additional, Wang, Zhiwei, additional, Aljurf, Mahmoud, additional, Akpek, Görgün, additional, Atsuta, Yoshiko, additional, Beattie, Sara, additional, Bredeson, Christopher N., additional, Burns, Linda J., additional, Chen, Allen R., additional, Dehn, Jason, additional, Freytes, César O, additional, Gupta, Vikas, additional, Hale, Gregory A., additional, Inamoto, Yoshihiro, additional, Lazarus, Hillard M., additional, LeMaistre, Charles F., additional, Palmer, Jeanne M., additional, Paulson, Kristjan, additional, Schears, Raquel M., additional, Steinberg, Amir, additional, Szwajcer, David, additional, Wingard, John R., additional, Wirk, Baldeep, additional, Wood, William A., additional, Joffe, Steven, additional, Hahn, Theresa, additional, Loberiza, Fausto R., additional, and Lee, Stephanie J., additional

Published
2014
Full Text
View/download PDF

13. Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

Author

Bacher, Ulrike, primary, Klyuchnikov, Evgeny, additional, Le-Rademacher, Jennifer, additional, Carreras, Jeanette, additional, Armand, Philippe, additional, Bishop, Michael R., additional, Bredeson, Christopher N., additional, Cairo, Mitchell S., additional, Fenske, Timothy S., additional, Freytes, Cesar O., additional, Gale, Robert Peter, additional, Gibson, John, additional, Isola, Luis M., additional, Inwards, David J., additional, Laport, Ginna G., additional, Lazarus, Hillard M., additional, Maziarz, Richard T., additional, Wiernik, Peter H., additional, Schouten, Harry C., additional, Slavin, Shimon, additional, Smith, Sonali M., additional, Vose, Julie M., additional, Waller, Edmund K., additional, and Hari, Parameswaran N., additional

Published
2012
Full Text
View/download PDF

14. Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study

Author

Armand, Philippe, primary, Perez, Waleska, additional, Zhang, Mei-Jie, additional, Kim, Haesook, additional, Klumpp, Thomas R., additional, Cin, Paola Dal, additional, Waller, Edmund K, additional, Litzow, Mark R., additional, Liesveld, Jane L., additional, Lazarus, Hillard M., additional, Artz, Andrew, additional, Gupta, Vikas, additional, Savani, Bipin N., additional, McCarthy, Philip L., additional, Cahn, Jean-Yves, additional, Schouten, Harry, additional, Finke, Jurgen, additional, Ball, Edward D., additional, Aljurf, Mahmoud, additional, Cutler, Corey, additional, Rowe, Jacob M., additional, Antin, Joseph H., additional, Isola, Luis M, additional, Bartolomeo, Paolo Di, additional, Camitta, Bruce, additional, Miller, Alan M, additional, Cairo, Mitchell S., additional, Stockerl-Goldstein, Keith E., additional, Sierra, Jorge, additional, Savoie, Mary Lynn, additional, Halter, Joerg, additional, Stiff, Patrick J, additional, Nabhan, Chadi, additional, Jakubowski, Ann A., additional, Bunjes, Donald, additional, Petersdorf, Effie W., additional, Devine, Steven M, additional, Maziarz, Richard, additional, Bornhauser, Martin, additional, Lewis, Victor A, additional, Marks, David I., additional, Bredeson, Christopher N, additional, Soiffer, Robert, additional, and Weisdorf, Daniel J., additional

Published
2010
Full Text
View/download PDF

15. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

Author

Schrezenmeier, Hubert, Passweg, Jakob R., Marsh, Judith C.W., Bacigalupo, Andrea, Bredeson, Christopher N., Bullorsky, Eduardo, Camitta, Bruce M., Champlin, Richard E., Gale, Robert Peter, Fuhrer, Monika, Klein, John P., Locasciulli, Anna, Oneto, Rosi, Schattenberg, Antonius V.M.B., Socie, Gerard, and Eapen, Mary

Published
2007
Full Text
View/download PDF

18. Biologic Assignment Clinical Trials in Hematopoietic Stem Cell Transplantation (HSCT) for Multiple Myeloma: Baseline Characteristics by Treatment Allocation from BMT CTN 0102 According to Availability of an HLA-Matched Sibling Donor.

Author

Pasquini, Marcelo C., Ewell, Marian, Stadtmauer, Edward A., Bredeson, Christopher N., Alyea, Edwin P., Stockerl-Goldstein, Keith, Krishnan, Amrita, Sahebi, Firoozeh, Rowley, Scott D., Maloney, David G., Vesole, David H., Horowitz, Mary M., Carter, Shelly, Geller, Nancy, Giralt, Sergio, and Blood Marrow Transplant Clinical Trials Network (BMT CTN)

Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results